title: The potential of insulin-like growth factor-I as a therapeutic for the treatment of neuromuscular disorders.
authors.affiliation: Cephalon, Inc., West Chester, Pennsylvania 19380.
authors.forename: M E
authors.initials: ME
authors.lastname: Lewis
authors.forename: J L
authors.initials: JL
authors.lastname: Vaught
authors.forename: N T
authors.initials: NT
authors.lastname: Neff
authors.forename: P E
authors.initials: PE
authors.lastname: Grebow
authors.forename: K V
authors.initials: KV
authors.lastname: Callison
authors.forename: E
authors.initials: E
authors.lastname: Yu
authors.forename: P C
authors.initials: PC
authors.lastname: Contreras
authors.forename: F
authors.initials: F
authors.lastname: Baldino
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy; D000818:Animals; D016923:Cell Death / Q000187:drug effects; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D009409:Nerve Crush; D009468:Neuromuscular Diseases / Q000188:drug therapy*; D009474:Neurons / Q000166:cytology / Q000187:drug effects; D010525:Peripheral Nerves / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D013116:Spinal Cord / Q000166:cytology / Q000187:drug effects / Q000378:metabolism
chemical_list: D011994:Recombinant Proteins; D007334:Insulin-Like Growth Factor I